Company / Current Assets per Share
Immunovant, Inc. Current Assets per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$4.39
FY2024
5-year range
$1.24 / $4.39
FY2020-FY2024
Trend
+50.0%
vs FY2023
Sector context
#147 of 212
Health Care
What the data says
At $4.39, Immunovant, Inc.'s current assets per share ranks #147 of 212 in the Health Care sector. Improved from $4.17 to $4.39 over the past 2 years.
Based on SEC 10-K filings.
4.39 in FY2024 with a 5-year CAGR of +72.1%.
Improved from $4.17 to $4.39 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +5.6%
- 5-Year CAGR
- +72.1%
- 10-Year CAGR
- -
Sector benchmark
#147 of 212 in Health CareTop 69% of 212This company $4.39 Sector average $133.20
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2024, current assets per share increased 50.0% year-over-year.
- Ranks #147 out of 212 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.39 | +50.0% |
| FY2023 | $2.93 | -29.7% |
| FY2022 | $4.17 | +11.8% |
| FY2021 | $3.73 | +200.0% |
| FY2020 | $1.24 | +326.9% |
| FY2019 | $0.29 | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026